Endothelium
Endothelium(内皮)
Endothelium 相关产品(32)
- GC402027α-hydroxy Cholesterol-d7CAS: 349553-94-2纯度: >99.00%
An internal standard for the quantification of 7α-hydroxy cholesterol
- GC40228Fluvastatin-d6 (sodium salt)纯度: >95.00%
An internal standard for the quantification of fluvastatin
- GC42809Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt)纯度: >95.00%
A peptide vasoconstrictor
- GC42930Big Endothelin-1 (1-38) (human) (trifluoroacetate salt)纯度: >95.00%
A peptide precursor of endothelin-1
- GC42970Brain Natriuretic Peptide (1-32) (human) (trifluoroacetate salt)纯度: >95.00%
A peptide with cardiovascular functions
- GC43727Ganglioside GD1a mixture (sodium salt)CAS: 12707-58-3纯度: >98.00%
A mixture of ganglioside G D1a
- GC44446NO-Losartan ACAS: 791122-48-0纯度: >97.00%
A potent AT 1 receptor antagonist linked to an NO-donor
- GC45501Lisinopril-d5CAS: 1356905-39-9纯度: >99.00%
An internal standard for the quantification of lisinopril
- GC4647418-DeoxyherboxidieneCAS: 1200128-66-0纯度: >70.00%
A bacterial metabolite with antiangiogenic activity
- GC48078Sildenafil-d3CAS: 1126745-90-1纯度: >99.50%
An internal standard for the quantification of sildenafil
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40202 | 7α-hydroxy Cholesterol-d7 | 349553-94-2 | >99.00% | |
An internal standard for the quantification of 7α-hydroxy cholesterol | ||||
| GC40228 | Fluvastatin-d6 (sodium salt) | - | >95.00% | |
An internal standard for the quantification of fluvastatin | ||||
| GC40430 | (±)14(15)-EET | 197508-62-6 | >98.00% | |
An arachidonic acid metabolite | ||||
| GC41104 | 20-carboxy Arachidonic Acid | 79551-84-1 | >98.00% | |
A metabolite of 20-HETE | ||||
| GC42809 | Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC42930 | Big Endothelin-1 (1-38) (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide precursor of endothelin-1 | ||||
| GC42970 | Brain Natriuretic Peptide (1-32) (human) (trifluoroacetate salt) | - | >95.00% | |
A peptide with cardiovascular functions | ||||
| GC43233 | CG 4305 | - | >95.00% | |
A stable PGI 2 analog with antithrombotic properties | ||||
| GC43727 | Ganglioside GD1a mixture (sodium salt) | 12707-58-3 | >98.00% | |
A mixture of ganglioside G D1a | ||||
| GC43732 | Ganglioside GM3 Mixture (sodium salt) | 54827-14-4 | >98.00% | |
A mixture of ganglioside G M3 | ||||
| GC44446 | NO-Losartan A | 791122-48-0 | >97.00% | |
A potent AT 1 receptor antagonist linked to an NO-donor | ||||
| GC45501 | Lisinopril-d5 | 1356905-39-9 | >99.00% | |
An internal standard for the quantification of lisinopril | ||||
| GC46474 | 18-Deoxyherboxidiene | 1200128-66-0 | >70.00% | |
A bacterial metabolite with antiangiogenic activity | ||||
| GC46706 | 5-Methyltetrahydrofolic Acid (hydrate) | - | >98.00% | |
叶酸的生物活性形式 | ||||
| GC47053 | CAY10746 | 2247240-76-0 | >95.00% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC47284 | Elaidic Acid-d17 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47598 | Maresin 1-d5 | 1268720-28-0 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48078 | Sildenafil-d3 | 1126745-90-1 | >99.50% | |
An internal standard for the quantification of sildenafil | ||||
| GC48122 | Tafluprost (free acid)-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48123 | Tafluprost-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48406 | PSI (trifluoroacetate salt) | - | >95.00% | |
A proteasome inhibitor | ||||
| GC49305 | H-Arg-Gly-Asp-Cys-OH (trifluoroacetate salt) | - | >95.00% | |
An RGD-containing tetrapeptide | ||||
| GC49403 | Benzarone | 1477-19-6 | >98.00% | |
An active metabolite of benzbromarone | ||||
| GC49406 | ACT-373898 | 1433875-14-9 | >90.00% | |
A metabolite of macitentan | ||||